E-cadherin and Fibronectin Expressions Have No Prognostic Role in Stage II Ductal Breast Cancer

• Published in: Anticancer research Vol. 25; no. 4; pp. 2879 - 2883
• Main Authors: SWIATONIOWSKI, Grzegorz, MATKOWSKI, Rafal, SUDER, Elzbieta, BRUZEWICZ, Szymon, SETTA, Monika, KORNAFEL, Jan, POLOZOWSKI, Andrzej, SUROWIAK, Pawel
• Format: Journal Article
• Language: English
• Published: Attiki International Institute of Anticancer Research 01.07.2005
• Subjects: Adult; Aged; Aged, 80 and over; Biological and medical sciences; Biomarkers, Tumor - biosynthesis; Breast Neoplasms - metabolism; Breast Neoplasms - pathology; Cadherins - biosynthesis; Carcinoma, Ductal - metabolism; Carcinoma, Ductal - pathology; Disease-Free Survival; Female; Fibronectins - biosynthesis; Humans; Immunohistochemistry; Medical sciences; Middle Aged; Neoplasm Staging; Tumors; Mammary gland diseases; ductal breast cancer; Cancerology; Prognosis; Cell adhesion molecule; Early stage; Breast cancer; Malignant tumor; E Cadherin; E-cadherin; Fibronectin

Background: The aim of the study was to describe the expressions of E-cadherin (EC) and fibronectin (FN) and their prognostic value in radically-treated ductal breast cancer. Patients and Methods: Ninety-eight patients, aged 26-86 (median, 57) with stage II G2 or G3 tumors, were subjected to a retro...